PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2004 December; 5(4): 10–17.
Published online 2004 September 17. doi:  10.1208/pt050452
PMCID: PMC2750477

Characterization of reservoir-type microcapsules made by the solvent exchange method

Abstract

The purpose of this reseach was to characterize and optimize the properties of microcapsules produced by the solvent exchange method, a new microencapsulation technique. Reservoir-type microcapsules containing lysozyme as a model protein were produced using a coaxial ultrasonic atomizer under various formulation and instrument settings, and characterized with respect to in vitro release kinetics and stability of the encapsulated protein. The solvent exchange method could encapsulate protein drugs with high efficiency under an optimized condition and was mild enough to preserve the integrity of the encapsulated lysozymes during the process. In vitro release studies showed that the microcapsules could release proteins in a controllable manner. The solvent exchange method is a mild and simple microencapsulation method that could encapsulate lysozyme, maintaining its functional integrity.

Keywords: microencapsulation, solvent exchange, ultrasonic atomizer, reservoir-type microcapsules, protein stability

Full Text

The Full Text of this article is available as a PDF (260K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME. Release of human serum albumin from PLGA microspheres. Pharm Res. 1990;7:1190–1194. doi: 10.1023/A:1015948829632. [PubMed] [Cross Ref]
2. Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst. 2002;19:73–98. doi: 10.1615/CritRevTherDrugCarrierSyst.v19.i1.20. [PubMed] [Cross Ref]
3. Lu W, Park TG. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. PDA J Pharm Sci Technol. 1995;49:13–19. [PubMed]
4. Blanco MD, Alonso MJ. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm. 1997;43:287–294. doi: 10.1016/S0939-6411(97)00056-8. [Cross Ref]
5. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable PLGA. Nat Biotechnol. 2000;18:52–57. doi: 10.1038/71916. [PubMed] [Cross Ref]
6. Capan Y, Jiang G, Giovagnoli S, Na K-H, DeLuca PP. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS PharmSciTech. 2003;4(2):E28–E28. doi: 10.1208/pt040228. [PMC free article] [PubMed] [Cross Ref]
7. Perez C, Castellanos IJ, Costantino HR, Al-Azzam W, Griebenow K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J Pharm Pharmacol. 2002;54:301–313. doi: 10.1211/0022357021778448. [PubMed] [Cross Ref]
8. Yeo Y, Basaran OA, Park K. A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation. J Control Release. 2003;93:161–173. doi: 10.1016/j.jconrel.2003.08.021. [PubMed] [Cross Ref]
9. Yeo Y, Park K. A new microencapsulation method using an ultrasonic atomizer based on interfacial solvent exchange.J Control Release. 2004; In press. [PubMed]
10. Berger HL. Ultrasonic Liquid Atomization. 1st ed. Hyde Park, NY: Partridge Hill Publishers; 1998.
11. Sah H. A new strategy to determine the actual protein content of PLGA microspheres. J Pharm Sci. 1997;86:1315–1318. doi: 10.1021/js960363q. [PubMed] [Cross Ref]
12. Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide) J Control Release. 2004/9;41(3):249–257. doi: 10.1016/0168-3659(96)01332-6. [Cross Ref]
13. Chongprasert S, Knopp SA, Nail SL. Characterization of frozen solutions of glycine. J Pharm Sci. 2001;90:1720–1728. doi: 10.1002/jps.1121. [PubMed] [Cross Ref]
14. O Hagan DT, Jeffery H, Davis SS. The preparation and characterization of PLGA microspheres: III. Microparticles/polymer degradation rates and the in vitro release of a model protein. Int J Pharm. 1994;103:37–45. doi: 10.1016/0378-5173(94)90201-1. [Cross Ref]
15. Rafati H, Coombes AGA, Adler J, Holland J, Davis SS. Protein-loaded PLGA microparticles for oral administration: formulation, structural and release characteristics. J Control Release. 1997;43:89–102. doi: 10.1016/S0168-3659(96)01475-7. [Cross Ref]
16. Li X, Deng X, Yuan M, et al. Investigation on process parameters involved in preparation of polylactide-poly(ethylene glycol) microspheres containingLeptospira interrogans antigens. Int J Pharm. 1999;178(2):245–255. doi: 10.1016/S0378-5173(98)00379-2. [PubMed] [Cross Ref]
17. Hsu Y-Y, Hao T, Hedley ML. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. J Drug Target. 1999;7:313–323. doi: 10.3109/10611869909085514. [PubMed] [Cross Ref]
18. Yang Y-Y, Chung T-S, Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials. 2001/2;22(3):231–241. doi: 10.1016/S0142-9612(00)00178-2. [PubMed] [Cross Ref]
19. Ghaderi R, Carlfors J. Biological activity of Lysozyme after entrapment in PLGA-microspheres. Pharm Res. 1997;14:1556–1562. doi: 10.1023/A:1012122200381. [PubMed] [Cross Ref]
20. Park TG, Lee HY, Nam YS. A new preparation method for protein loaded poly(,-lactic-co-glycolic acid) microspheres and protein release mechanism study. J Control Release. 1998;55:181–191. doi: 10.1016/S0168-3659(98)00050-9. [PubMed] [Cross Ref]
21. Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(d,l-lactide-co-glycolide) microspheres. J Control Release. 2002;79:137–145. doi: 10.1016/S0168-3659(01)00533-8. [PubMed] [Cross Ref]
22. Aubert-Pouesel A, Bibby DC, Venier-Julienne M-C, Hindre F, Benoit J-P. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm Res. 2002;19:1046–1051. doi: 10.1023/A:1016482809810. [PubMed] [Cross Ref]
23. Sah H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J Pharm Sci Technol. 1999;53:3–10. [PubMed]
24. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185:129–188. doi: 10.1016/S0378-5173(99)00152-0. [PubMed] [Cross Ref]
25. Nail SL. Formulation of proteins and peptides. In: Park K, editor. Controlled Drug Delivery Challenges and Strategies. Washington, DC: ACS Professional Reference Book; 1997. pp. 185–203.
26. Pikal MJ. Freze-drying of proteins: process, formulations, and stability. In: Cleland JL, Langer R, editors. Formulation and Delivery of Proteins and Peptides. Washington, DC: ACS; 1994. pp. 121–133.
27. Weert M, Hennink WE, Jiskoot W. Protein instability in PLGA microparticles. Pharm Res. 2000;17:1159–1167. doi: 10.1023/A:1026498209874. [PubMed] [Cross Ref]
28. Kim TH, Park TG. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm. 2004;271:207–214. doi: 10.1016/j.ijpharm.2003.11.021. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists